EP2977757B1 - Disposable chamber for analyzing biologic fluids - Google Patents

Disposable chamber for analyzing biologic fluids Download PDF

Info

Publication number
EP2977757B1
EP2977757B1 EP15178645.6A EP15178645A EP2977757B1 EP 2977757 B1 EP2977757 B1 EP 2977757B1 EP 15178645 A EP15178645 A EP 15178645A EP 2977757 B1 EP2977757 B1 EP 2977757B1
Authority
EP
European Patent Office
Prior art keywords
planar
separators
chamber
tape
height
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP15178645.6A
Other languages
German (de)
French (fr)
Other versions
EP2977757A1 (en
Inventor
Stephen C. Wardlaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US56030704P priority Critical
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to EP05732677.9A priority patent/EP1733226B1/en
Publication of EP2977757A1 publication Critical patent/EP2977757A1/en
Application granted granted Critical
Publication of EP2977757B1 publication Critical patent/EP2977757B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/4875Details of handling test elements, e.g. dispensing or storage, not specific to a particular test method
    • G01N33/48764Test tape taken off a spool
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502738Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by integrated valves
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/2813Producing thin layers of samples on a substrate, e.g. smearing, spinning-on
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/36Embedding or analogous mounting of samples
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
    • G01N21/01Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03Cuvette constructions
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/492Determining multiple analytes
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS, OR APPARATUS
    • G02B21/00Microscopes
    • G02B21/34Microscope slides, e.g. mounting specimens on microscope slides
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/02Adapting objects or devices to another
    • B01L2200/025Align devices or objects to ensure defined positions relative to each other
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/12Specific details about manufacturing devices
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0861Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0877Flow chambers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0887Laminated structure
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0403Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0406Moving fluids with specific forces or mechanical means specific forces capillary forces
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30Staining; Impregnating Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • G01N1/31Apparatus therefor
    • G01N1/312Apparatus therefor for samples mounted on planar substrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N2015/0065Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials biological, e.g. blood
    • G01N2015/008White cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N2015/1006Investigating individual particles for cytology
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Electro-optical investigation, e.g. flow cytometers
    • G01N2015/1486Counting the particles
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
    • G01N21/01Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03Cuvette constructions
    • G01N2021/0346Capillary cells; Microcells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
    • G01N21/01Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03Cuvette constructions
    • G01N2021/0364Cuvette constructions flexible, compressible
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00009Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor provided with a sample supporting tape, e.g. with absorbent zones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Description

    BACKGROUND OF THE INVENTION 1. Technical Field
  • The present invention relates to chambers for analyzing biologic fluids in general, and to chambers that permit the enumeration of particulate matter within the biologic fluid in particular.
  • 2. Background Information
  • The classic method of enumerating particles in a liquid medium, such as blood cells in whole blood or bacteria or other material in urine or other biologic fluid is the hemocytometer, which includes a chamber manufactured to a precise height and having visible ruled areas of precise dimension. The liquid containing the particles to be enumerated is introduced into the chamber. The liquid is diluted if necessary to reduce the number of particles to a manageable number. The operator then counts the number of particles in a given demarcated area. Since the area and height of the chamber are precisely known, the particle count per volume can be calculated. Although these chambers are generally ruled to demarcate a known area, this is not necessary if such a chamber is used in an image analyzer. With an image analyzer, rulings on the chamber itself are unnecessary because the field of view can be exactly calculated from the image.
  • Because they are precisely manufactured, hemocytometer chambers are relatively expensive and were not considered disposable. Modem precision plastics molding techniques have allowed the manufacture of some types of hemocytometer chambers at sufficiently low cost so as to be considered disposable in some instances, but chambers requiring substantial precision and/or thicknesses less than the traditional 0.1 mm are very difficult to mold accurately.
  • U.S. Patent No. 4,950,455 describes a counting chamber formed from a rigid glass slide and a rigid glass coverslip with rigid particles, such as glass beads, contained therebetween. The beads maintain a thin spacing between the slide and coverslip, thereby forming the counting chamber.
  • A counting chamber formed from rigid upper and lower panels separated by rigid particles has substantial limitations, however. Referring to FIGS. 1 and 2, a prior art assembly generally denoted by 2 consists of a lower glass slide 3, an upper glass coverslip 4 and an entrapped layer formed from a plurality of glass beads 5. Because any microscopic beads are not completely uniform, having a coefficient of variation of the diameter of up to 10% or greater, the larger beads 6 "prop-up" the coverslip 4 to some extent, and the smaller beads 7 have no effect on the separation. The differences in bead diameter is a problem because while it is easy to determine and/or control the mean diameter of the beads, the spread of diameters is less well controlled, rendering the system less accurate than is desired. This results in a separation between the upper and lower layers of about the mean bead diameter plus one standard deviation. A greater problem is the presence of particulate debris as shown in FIG. 2. This debris can be present when the chamber is made or can be introduced by the environment or from a sample. The debris 8 can "prop up" the coverslip 4 and create a large area of increased volume in the chamber, which destroys its accuracy.
  • Another issue with this type of prior art chamber is that it is difficult to package a plurality of such disposables in an instrument used for automatically scanning and counting particles, such as an image analyzing system. Another examples of the prior art are shown in US4264560 , GB1049364 or US3447863 . What is needed is an apparatus and method to overcome the limitations of the prior art, that provides a chamber for analyzing biologic fluids, including the enumeration of particulates within the fluid, which is inexpensive to produce, relatively insensitive to trapped particulate debris, and amenable to packaging for use in an automated test system.
  • SUMMARY OF THE INVENTION
  • According to a first aspect of the present invention there is provided an apparatus for analyzing biologic fluid as claimed in claim 1.
    In one embodiment the apparatus further comprises:
    • a pair of nip-rollers, spaced apart from one another an amount that causes the first planar member and second planar member to be in contact with substantially all of the separators when the planar members are drawn between the nip-rollers;
    • wherein the chamber is formed downstream of the nip-rollers.
  • In some preferred embodiments the at least one chamber includes a port.
  • Preferably at least one of the first planar member and the second planar member comprise flexible plastic. Further preferably, both of the first planar member and the second planar member comprise flexible plastic.
  • Preferably the separators are flexible relative to the first planar member and second planar member.
  • Preferably one of the separators, first planar member, and second planar member, has a greater flexibility relative to at least one of the others of the separators, first planar member, and second planar member. Further preferably, the first planar member has a greater flexibility than the second planar member and the separators.
  • Preferably the separators are attached to at least one of the first planar member or the second planar member.
  • Preferably at least one of the first planar member or the second planar member comprises linked rigid elements.
  • Preferably one of the first planar member or the second planar member comprises linked rigid elements and the other of the first planar member or second planar member comprises flexible plastic.
  • Preferably the separators include uniformly dyed, slightly compressible plastic beads.
  • Preferably the separators are projections of uniform height attached to at least one of the first planar member or second planar member.
  • Preferably one of the first planar member or the second planar member comprises one or more ports.
  • According to one embodiment of the present invention, each planar member is a tape that can be wound on a reel. In some embodiments, the planar members are initially attached to one another. In other embodiments, each planar member is initially separated from the other planar member.
  • According to one embodiment of the present invention, a cassette is provided having at least one source reel and at least one take-up reel. The planar members are initially wound on a source reel, and are transferred to a take-up reel during operation of the apparatus. An analysis region is disposed between the source and take-up reels. The planar members pass through the analysis region during the operation of the apparatus.
  • The present invention extends to a method of enumerating the cellular or particulate constituents of a sample of whole, anticoagulated blood, as claimed in claim 14.
  • Preferably the biologic fluid is blood. The method preferably further comprises the step of calculating the chamber height by measuring the average attenuation of light transmitted through the separators. Preferably the step of determining the volume of biologic fluid contained within the film further comprises the steps of: determining the area of the film; and calculating the volume of biologic fluid by multiplying the chamber height times the area of the film.
  • Preferably the film volume is calculated by interferometric imaging of the drop of biologic fluid deposited onto the planar member prior to approximating the planar members.
  • There are numerous advantages with associated the present invention. We discovered that if a counting chamber is produced using separators disposed between planar members, and if at least one the planar members and separators is flexible, the chamber behaves differently than the prior art devices, and the difference is highly advantageous. When a counting chamber is filled with a liquid, the capillary forces tend to pull the top and bottom planar members together, thus exerting a slight pressure on the retained separators. This pressure will cause the flexible element to deform in such a manner as to cause the chamber thickness to approximate, on average, the mean dimension of the separators disposed between the planar members. For example, if both top and bottom planar members are rigid and the separators are flexible, separators larger than the mean diameter will be compressed, and the planar members will approximate until more and more separators come into contact with the planar members, preventing further approximation. At that point, the height of the chamber approximates the average height of the separators and is readily ascertainable. In another example, if the separators are rigid and the top planar member is flexible, the top planar member will deform and be "tented-up" in a small area around each of the larger separators and be lower over smaller separators. The chamber will have an average height which closely approximates average separator height.
  • An advantage of the present invention is, therefore, that a chamber is formed having a volume that is accurately determinable because the height of the chamber is substantially uniform.
  • Another advantage of the present invention is that it can be manufactured in an inexpensive form and still provide the desired accuracy. The present invention does not require accurately machined voids or separators to accurately establish volume. Consequently, the invention can be manufactured inexpensively and still provide the desired accuracy. In addition, because it can be manufactured inexpensively, the present invention can practically be offered in a disposable form.
  • These and other objects, features and advantages of the present invention will become apparent in light of the detailed description of the invention provided below, and as illustrated in the accompanying drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The principles of the invention are further clarified by referring to the following figures, where:
    • FIG. 1 is a cross-sectional schematic of the invention of the prior art, using a system in which all elements are rigid;
    • FIG. 2 is a cross-sectional schematic of the invention of the prior art, using a system in which all elements are rigid, and where particulate debris has been trapped;
    • FIG. 3 is a cross-sectional schematic of the present invention, where the separators are flexible relative to the top and bottom planar members;
    • FIG. 4 is a cross-sectional schematic of the present invention, where the top planar member is flexible in relation to all other elements;
    • FIG. 5 is a cross-sectional schematic of the present invention, where the top planar member is flexible in relation to all other elements and where particulate debris has been trapped;
    • FIG. 6 is a schematic view of a first embodiment of the present invention;
    • FIG. 6A is a schematic view of an instrument designed to utilize a second embodiment of the present invention;
    • FIG. 7 is a schematic view of a cassette containing the first embodiment of the present invention;
    • FIG. 8 is a schematic view of an instrument designed to utilize an embodiment of the present invention;
    • FIG. 9 is a schematic view of the instrument of FIG. 6 where the sample has been added to the planar member;
    • FIG. 10 is a schematic view of the sample after spreading out between the planar members; and
    • FIG. 11 is a schematic view of a typical field of view.
    DETAILED DESCRIPTION OF THE INVENTION
  • Referring to FIGS. 3-11, the present invention apparatus 10 for analyzing biologic fluid includes a first planar member 12, a second planar member 14, and at least three separators 16. At least one of planar members 12, 14 is transparent. The separators 16 are disposed between the members 12, 14, and separate the planar members 12, 14 to form a chamber 18 having a height 20. At least one of the members 12, 14 or separators 16 is sufficiently flexible to permit the chamber height 20 between the members 12, 14 to approximate the mean height of the separators 16.
  • The separators 16 can be any structure that is disposable between the planar members 12, 14, operable to space the planar members 12, 14 apart from one another. The dimension of a separator 16 that extends between the planar members is referred to herein as the height 22 of the separator 16. The heights 22 of the separators 16 typically do not equal one another exactly, but are within commercially acceptable tolerance for spacing means used in similar analysis apparatus. Spherical beads are an example of an acceptable separator 16 and are commercially available from, for example, Bangs Laboratories of Fishers, Indiana, USA.
  • In some embodiments, the separators 16 consist of a material that has greater flexibility than one or both of the first planar member 12 and the second planar member 14; i.e., relatively speaking, one or both of the planar members 12, 14 may be considered to be rigid relative to the separators 16 and the separators 16 may be considered to be flexible relative to one or both of the planar members 12, 14.
  • In other embodiments, the separators 16 consist of a material that has less flexibility than one or both of the first planar member 12 and the second planar member 14; i.e., relatively speaking, one or both of the planar members 12, 14 may be considered to be flexible relative to the separators 16 and the separators 16 may be considered to be rigid relative to one or both of the planar members 12, 14.
  • Subject to the flexibility characteristics described above, the planar members 12, 14 can be made from a variety of materials, provided at least one of the planar members 12, 14 is transparent. Transparent plastic films consisting of acrylic or polystyrene are examples of acceptable planar members 12, 14. Planar members 12, 14 in the form of a tape are particularly useful because they can be easily wound on a reel.
  • Now referring to FIG. 3, in an embodiment of the present invention 10 the first planar member 12 and the second planar member 14 are separated by a chamber 18 formed by plurality of separators 16 in the form of spherical beads. These beads 16 are formed from a material that has greater flexibility than the first planar member 12 and the second planar member 14; i.e., the planar members 12, 14 may be considered to be rigid relative to the beads 16 and the beads 16 may be considered to be flexible relative to the planar members 12, 14. Plastic beads 16 formed from polystyrene, polycarbonate, silicone and the like can be used. In this example, larger beads 16A are compressed to the point where the planar members 12, 14 have approximated to the point where most beads 16 are touching the interior surfaces 24 of the planar members 12, 14, thereby making the chamber height 20 just slightly less than the mean bead diameter.
  • In FIG. 4, in another embodiment of the present invention 10 the first planar member 12 is formed from a material more flexible than the spherical beads 16 and the second planar member 14, and will overlay the beads 16 in a tent-like fashion, where the areas between the beads 16 are some arbitrary height determined by the bead diameters supporting that piece of the planar member 12. Any transparent plastic film, such as acrylic, polystyrene, or the like will work provided it is thin enough to flex as shown. It should be apparent that in this circumstance, although small local areas will deviate from the desired chamber height 20, the average height of all the tented areas will be very close to that of the mean bead diameter. Our testing indicates that that the mean chamber height can be controlled to 1% or better at chamber heights of less than four microns using the present invention.
  • FIG. 5 shows the chamber 18 of FIG. 4 wherein a piece of particulate debris 26 has lodged. The upper planar member 12 over the debris 26 has tented up, and the area under the debris 26 is of unknown height, but this disturbance only affects a small area of the chamber 18, as opposed to what would occur if the whole system was rigid.
  • FIG. 6 shows another embodiment of the invention 10, where the second planar member 14 is formed from a one inch wide strip of transparent plastic film (e.g., polyethylene terphthalate (PET)) of approximately fifty (50) microns in thickness, the first planar member 12 is formed from the same material as the second planar member 14 but in twenty-three (23) micron thickness, and the chamber 18 therebetween is formed from a plurality of plastic beads 16 with a mean diameter of four (4) microns. The first planar member 12 has an inner coating of a coloration agent, such as acridine orange, which will differentially color living white blood cells when examined with fluorescent illumination. Other reagents for fluorescence include astrozone orange, FITC, rhodamine and the like. Reagents which may be used with transmitted light to differentially color the white blood cells include astrozone orange, methylene blue, oxazine170. The first planar member 12 includes a plurality of ports 28 (e.g., approximately three hundred (300) microns in diameter) punched at regular intervals, and the planar members 12, 14 are bonded at some points 29 between the ports 28 to form a series of separated analysis chambers 18.
  • This spacing between the two planar members 12, 14 in this embodiment is accomplished by spherical beads 16 of known and precisely controlled diameter (e.g., about four (4) microns in diameter). These beads 16 are randomly distributed on at least one of the planar members 12, 14 and can be attached as part of the reagent film containing the staining material. The material retaining the beads 16 should be such that they remain affixed to the planar member 12, 14 until at least after the fluid film movement has ceased so that they will not be swept away. An acceptable method of coating a film with beads 16 is to suspend the beads 16 in approximately a 0.5% solution of phytagel and apply a thin coating of the suspension by either spraying or meniscus coating. The optimum concentration of beads 16 will depend upon the type of bead and their method of manufacture, as well as the relative rigidity of the top and bottom planar members 12, 14. This concentration can be determined empirically on a batch-to-batch basis by applying a series of bead concentrations to the planar members 12, 14 to be used and then adding a liquid containing a dye, such as hemoglobin, which will give a useful optical density at the liquid layer thickness used. The average optical density of the liquid layer is then plotted against bead 16 density to determine the point where additional bead concentration produces no useful change in liquid layer thickness; i.e., the point where the chamber height 20 is substantially uniform. An alternate means of providing the separators is to negatively emboss one of the planar members 12, 14 with projections having approximately the same height of about four (4) microns, for example by laser-etching pits in a nip-roller and passing one planar member 12, 14 through the nip-roller assembly.
  • FIG. 7 shows a cassette 30 having a shell 32 in which a source reel 34, a take-up reel 36, and a tape 38 extending therebetween are disposed. The "tape 38" is the embodiment of the present invention shown in FIG. 6 and described above. Initially, the tape 38 is wound on the source reel 34. Advancement of the tape 38 is controlled by rollers 40, which apply traction to the tape 38 at a point remote from the examination area 42 and can act to draw the tape 38 from the source reel 34 as required. The cassette 30 has a through-hole that allows an optical system to provide illumination through the tape 38.
  • FIG. 8 shows an optical analysis system 44 containing the cassette 32. The optical analysis system 44, which consists of joined components including a lens 46, a variable-wavelength light source 48 and a CCD camera 50 are movable in three dimensions so as to allow the optical system 44 to focus upon the tape 38 in the examination area 42 and provide X-Y movement so as to allow scanning of the entire examination area 42, all under control of a system computer 52. Not shown is the sampling probe for extracting a biologic fluid (e.g., blood) from a sample tube and depositing a small drop on the tape 38. This sampling device can take the form of a tube-piercing or similar probe, which uses a stepping motor-driven syringe to extract and deposit biologic fluid samples. These devices are widely employed and well known to the art, and therefore will not be described further here.
  • FIG. 9 shows the assembly of FIG. 8 just after a drop of biologic fluid 54 (e.g., blood) has been deposited into the sample entry port 28 (see FIG. 6) of a chamber 18 formed between the planar members 12, 14.
  • FIG. 10 is a schematic view of the entire area of the sample film 64 of biologic fluid 34, which generally has an irregular border. In this example, the biologic fluid is blood. Because the white blood cells within the sample film 64 tend to become readily entrapped in the chamber 18, they are generally found in highest concentration within a few millimeters of the port 28.
  • FIG. 11 is a schematic view of the analysis field 66 in FIG. 10, which, in the case of a whole blood sample, would show red blood cells 56, white blood cells 58, platelets 60, all surrounded by the blood plasma 62. The beads 16 are also seen but are readily distinguished from all other elements because of their size and refractive index.
  • The characterization of the white blood cells 58 (white blood cell differential count) is performed by the classification of each individual white blood cell 58 as it is encountered using either traditional image-processing methods or by the technique described in U.S. Patent Nos. 5,321,975 and 6,350,613 . A number of supravital stains have been described which differentially color the different classes of white blood cells 58 as has been described in U.S. Patent No. 6,235,536 . Because the white blood cells 58 are slightly compressed and readily imaged, stored images of cells are viewable by the technologist in the case of questionable cell classifications.
  • As an example of the utility of this invention, the white blood cell 58 count of the sample film 64 may be performed by enumerating all of the white blood cells 58 found within the sample film 64 and dividing that number by the volume of the sample film 64. Although it is possible to deposit a specific amount of sample within the chamber 18, it is preferable to deposit an approximate amount and indirectly measure the volume. This can be done by mechanisms such as: 1) the volume of the drop of sample when first deposited can be calculated by interferometric imaging using optical techniques available from sources such as the Zygo Corporation of Middlefield, Connecticut USA; or 2) the volume of sample following film formation is calculated by measuring the area of the film 64 and multiplying this by the average height of the film.
  • Figure 6A shows an optical analysis system 44 containing another embodiment of the present invention 10 that includes a cassette 30 in which a lower planar member reel 68, upper planar member reel 70, and take-up reel 72. Advancement of the planar members 12, 14 is controlled by take-up nip-rollers 74, which apply traction to the combined planar members 12, 14 at a point remote from the examination area 42 and can act to draw the planar members 12, 14 from their reels 68, 70 as required. The optical analysis system 44, which consists of joined components including a lens 46, a variable-wavelength light source 48 and a CCD camera 50 are movable in three dimensions so as to allow the optical analysis system 44 to focus upon the joined planar members 12, 14 in the examination area 42 and provide X-Y movement so as to allow scanning of the entire examination area 42, all under control of a system computer 52. A drop of biologic fluid 54 (e.g., blood) is shown deposited onto the second planar member 14. The nip-rollers 74 are operable to advance the planar members 12, 14 to a point just past the nip-rollers 74, where the separators 16 disposed between the planar members 12, 14 are in contact with each planar member 12, 14, and the biologic fluid contacts the interior surface 24 of each planar member 12, 14 and spreads to form a thin sample film 64. The planar members 12, 14 are then advanced so as to be readable by optical analysis system 44.
  • Since the overall accuracy of the system 44 when using a method of volume calculation depends upon the accuracy of the chamber height 20, it may be expedient to use an internal standard means to calculate the exact chamber height 20. An example of an internal standard includes a flexible or flowable material which is not miscible with the sample and which contains a known, stable and uniform concentration of a sensible optical dye. The material can be dyed flexible beads, dyed oil or the like, and may be present in one or more areas of the chamber 18. Since the optical density is in direct proportion to the thickness of the calibrator material, measurement of the optical density of the part of the calibrator material which completely fills the chamber height 20 will allow the calculation of the exact chamber height 20 to within the precision capabilities of the optical system.
  • Although the most frequent use for such a chamber 18 will be for enumerating blood cells in whole blood, it is equally useful for examination of any undiluted fluid having sufficient particles to count. The chamber height 20 is not limited to the disclosed four microns but can be larger or smaller to accommodate different separator sizes and/or concentrations.
  • Although this invention has been shown and described with respect to the detailed embodiments thereof, it will be understood by those skilled in the art that various changes in form and detail thereof may be made without departing from the scope of the invention, which is defined by the following claims.

Claims (14)

  1. An apparatus (10) for analyzing biologic fluid, comprising:
    a tape (38) including a first planar member (12) and a second planar member (14) spaced apart from one another and bonded together at discrete points, wherein at least one of the first planar member (12) and second planar member (14) is transparent, and at least one chamber (18) having a height (20) is formed between the planar members (12, 14), characterized in that at least three separators (16) are disposed in each of the at least one chamber (18), and wherein at least one of the first planar member (12), second planar member (14), or separators (16) is flexible to permit the chamber height (20) to be substantially uniform;
    a source reel (34) on which the tape (38) is wound; and
    a take-up reel (36) on which the tape (38) is wound.
  2. The apparatus (10) of claim 1, wherein the at least one chamber (18) includes a port (28).
  3. The apparatus (10) of any preceding claim, wherein one of the separators (16), first planar member (12), and second planar member (14), has a greater flexibility relative to at least one of the others of the separators (16), first planar member (12), and second planar member (14).
  4. The apparatus (10) of claim 3, wherein the first planar member (12) has a greater flexibility than the second planar member (14) and the separators (16).
  5. The apparatus (10) of any preceding claim, wherein at least one of the first planar member (12) and the second planar member (14) comprise flexible plastic.
  6. The apparatus (10) of claim 5, wherein both of the first planar member (12) and the second planar member (14) comprise flexible plastic.
  7. The apparatus (10) of any preceding claim, wherein the separators (16) are attached to at least one of the first planar member (12) or the second planar member (14).
  8. The apparatus (10) of any of claims 1-5, wherein one of the first planar member (12) or the second planar member (14) comprises linked rigid elements and the other of the first planar member (12) or second planar member (14) comprises flexible plastic.
  9. The apparatus (10) of any preceding claim, wherein the separators (16) include uniformly dyed, slightly compressible plastic beads.
  10. The apparatus (10) of any preceding claim, further comprising:
    a pair of nip-rollers (40), spaced apart from one another an amount that causes the first planar member (12) and second planar member (14) to be in contact with substantially all of the separators (16) when the planar members (12, 14) are drawn between the nip-rollers (40);
    wherein the chamber (18) is formed downstream of the nip-rollers (40).
  11. The apparatus (10) of claim 10, wherein one of the separators (16), first planar member (12), and second planar member (14), has a greater flexibility relative to at least one of the others of the separators (16), first planar member (12), and second planar member (14).
  12. The apparatus (10) of claim 11, wherein the first planar member (12) has a greater flexibility than the second planar member (14) and the separators (16).
  13. The apparatus (10) of claim 10 wherein one of the first planar member (12) or the second planar member (14) comprises linked rigid elements and the other of the first planar member (12) or second planar member (14) comprises flexible plastic.
  14. A method of enumerating the cellular or particulate constituents of a sample of whole, anticoagulated blood, comprising the steps of:
    providing a tape (38) including a first planar member (12) and a second planar member (14) spaced apart from one another and bonded together at discrete points, wherein at least one of the first planar member (12) and second planar member (14) is transparent, and at least one chamber (18) having a height (20) is formed between the planar members (12, 14), and at least three separators (16) are disposed in each of the at least one chamber (18), and wherein at least one of the first planar member (12), second planar member (14), or separators (16) is flexible to permit the chamber height (20) to be substantially uniform, a source reel (34) on which the tape (38) is wound, and a take-up reel (36) on which the tape (38) is wound;
    depositing a quantity of biologic fluid (54) into the at least one chamber (18);
    determining the volume of biologic fluid (54) contained within at least a portion of the at least one chamber (18);
    directly or indirectly enumerating all constituents of interest within substantially the volume of biologic fluid (54); and
    expressing the enumerated constituents as a count per unit volume.
EP15178645.6A 2004-04-07 2005-04-07 Disposable chamber for analyzing biologic fluids Active EP2977757B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US56030704P true 2004-04-07 2004-04-07
EP05732677.9A EP1733226B1 (en) 2004-04-07 2005-04-07 Disposable chamber for analyzing biologic fluids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17189563.4A EP3270156A1 (en) 2004-04-07 2005-04-07 Disposable chamber for analyzing biologic fluids

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
EP05732677.9A Division EP1733226B1 (en) 2004-04-07 2005-04-07 Disposable chamber for analyzing biologic fluids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP17189563.4A Division EP3270156A1 (en) 2004-04-07 2005-04-07 Disposable chamber for analyzing biologic fluids

Publications (2)

Publication Number Publication Date
EP2977757A1 EP2977757A1 (en) 2016-01-27
EP2977757B1 true EP2977757B1 (en) 2017-09-13

Family

ID=35150548

Family Applications (3)

Application Number Title Priority Date Filing Date
EP05732677.9A Active EP1733226B1 (en) 2004-04-07 2005-04-07 Disposable chamber for analyzing biologic fluids
EP15178645.6A Active EP2977757B1 (en) 2004-04-07 2005-04-07 Disposable chamber for analyzing biologic fluids
EP17189563.4A Pending EP3270156A1 (en) 2004-04-07 2005-04-07 Disposable chamber for analyzing biologic fluids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP05732677.9A Active EP1733226B1 (en) 2004-04-07 2005-04-07 Disposable chamber for analyzing biologic fluids

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP17189563.4A Pending EP3270156A1 (en) 2004-04-07 2005-04-07 Disposable chamber for analyzing biologic fluids

Country Status (8)

Country Link
US (4) US7850916B2 (en)
EP (3) EP1733226B1 (en)
JP (1) JP4362532B2 (en)
CN (1) CN1957254B (en)
AU (1) AU2005233571B2 (en)
CA (1) CA2563002C (en)
ES (2) ES2548567T3 (en)
WO (1) WO2005100539A2 (en)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1733226B1 (en) 2004-04-07 2015-07-29 Levine, Robert Aaron Disposable chamber for analyzing biologic fluids
US7731901B2 (en) 2005-10-19 2010-06-08 Abbott Laboratories Apparatus and method for performing counts within a biologic fluid sample
HU227018B1 (en) 2006-10-26 2010-04-28 77 Elektronika Mueszeripari Kf Container to examine urine
JP4887464B2 (en) * 2008-03-21 2012-02-29 アボット ポイント オブ ケア インコーポレイテッド Method and apparatus for determining a focal position of an imaging device configured to image a biological sample
ES2392380T3 (en) * 2008-03-21 2012-12-10 Abbott Point Of Care, Inc. Procedure and apparatus for determining the hematocrit of a blood sample using the intrinsic pigmentation of the hemoglobin contained in the red blood cells
JP5539309B2 (en) 2008-03-21 2014-07-02 アボット ポイント オブ ケア インコーポレイテッド Method and apparatus for determining the red blood cell index of a blood sample using the inherent dye of hemoglobin contained in red blood cells
CN102084241B (en) 2008-03-21 2015-02-18 艾博特健康公司 Method and apparatus for analyzing individual cells or particulates using fluorescent quenching and/or bleaching
WO2009117682A1 (en) 2008-03-21 2009-09-24 Abbott Point Of Care, Inc. Method and apparatus for detecting and counting platelets individually and in aggregate clumps
CN102047114B (en) * 2008-04-02 2014-10-29 艾博特健康公司 Self-calibrating gradient dilution in a constituent assay and gradient dilution apparatus performed in a thin film sample
CN102047116A (en) * 2008-04-09 2011-05-04 艾博特健康公司 Method of detecting very low levels of analyte within a thin film fluid sample contained in a thin thickness chamber
JP5734838B2 (en) * 2008-04-09 2015-06-17 アボット ポイント オブ ケア インコーポレイテッド Method for measuring the area of a sample placed in an analysis chamber
WO2010022019A1 (en) 2008-08-21 2010-02-25 Siemens Healthcare Diagnostics Inc. Multi-layer slides for analysis of urine sediments
US9395365B2 (en) * 2009-04-02 2016-07-19 Abbott Point Of Care, Inc. Detection of infectious disease in a human or animal by measuring specific phagocytosis in a thin film sample of their anticoagulated blood
US20100255605A1 (en) * 2009-04-02 2010-10-07 Abbott Point Of Care, Inc. Method and device for transferring biologic fluid samples
CA2778725C (en) 2009-10-28 2019-04-30 Alentic Microscience Inc. Microscopy imaging
US9075225B2 (en) 2009-10-28 2015-07-07 Alentic Microscience Inc. Microscopy imaging
US10502666B2 (en) 2013-02-06 2019-12-10 Alentic Microscience Inc. Sample processing improvements for quantitative microscopy
US10746752B2 (en) * 2009-11-13 2020-08-18 Ventana Medical Systems, Inc. Opposables and automated specimen processing systems with opposables
WO2013134742A2 (en) 2012-03-08 2013-09-12 Cyvek, Inc Micro-tube particles for microfluidic assays and methods of manufacture
US9500645B2 (en) 2009-11-23 2016-11-22 Cyvek, Inc. Micro-tube particles for microfluidic assays and methods of manufacture
US9700889B2 (en) 2009-11-23 2017-07-11 Cyvek, Inc. Methods and systems for manufacture of microarray assay systems, conducting microfluidic assays, and monitoring and scanning to obtain microfluidic assay results
US10065403B2 (en) 2009-11-23 2018-09-04 Cyvek, Inc. Microfluidic assay assemblies and methods of manufacture
US9759718B2 (en) 2009-11-23 2017-09-12 Cyvek, Inc. PDMS membrane-confined nucleic acid and antibody/antigen-functionalized microlength tube capture elements, and systems employing them, and methods of their use
US9651568B2 (en) 2009-11-23 2017-05-16 Cyvek, Inc. Methods and systems for epi-fluorescent monitoring and scanning for microfluidic assays
US9855735B2 (en) 2009-11-23 2018-01-02 Cyvek, Inc. Portable microfluidic assay devices and methods of manufacture and use
WO2011063408A1 (en) 2009-11-23 2011-05-26 Cyvek, Inc. Method and apparatus for performing assays
CA2784353C (en) 2009-12-18 2015-11-03 Abbott Point Of Care, Inc. Biologic fluid analysis cartridge
EP2519820B1 (en) 2009-12-31 2013-11-06 Abbott Point Of Care, Inc. Method and apparatus for determining mean cell volume of red blood cells
WO2011082109A2 (en) * 2009-12-31 2011-07-07 Abbott Point Of Care, Inc. Method and apparatus for securing planar orientation of analysis chamber
CN102782559B (en) * 2009-12-31 2015-11-25 雅培照护点公司 For focusing on method and the device of the image forming biological specimen fast
SG10201704217RA (en) * 2010-01-20 2017-06-29 Emd Millipore Corp Cell image capturing and remote monitoring systems
WO2011116305A1 (en) 2010-03-18 2011-09-22 Abbott Point Of Care, Inc. Method and apparatus for optically determining at least one hemoglobin related parameter of a whole blood sample
US9199233B2 (en) 2010-03-31 2015-12-01 Abbott Point Of Care, Inc. Biologic fluid analysis cartridge with deflecting top panel
WO2011123649A1 (en) 2010-03-31 2011-10-06 Abbott Point Of Care, Inc. Method and apparatus for selectively admixing reagents in a substantially undiluted biologic fluid sample analysis
WO2012012800A2 (en) 2010-07-23 2012-01-26 Abbott Point Of Care, Inc. A method and apparatus for detecting the presence of anisotropic crystals and hemozoin producing parasites in liquid blood
AU2011285527B2 (en) 2010-08-05 2014-10-30 Abbott Point Of Care, Inc. Method and apparatus for automated whole blood sample analyses from microscopy images
CN104169719B (en) 2011-12-29 2017-03-08 思迪赛特诊断有限公司 For detecting the method and system of pathogen in biological sample
CN103282123B (en) 2010-12-30 2015-05-06 艾博特健康公司 Biologic fluid analysis cartridge with sample handling portion and analysis chamber portion
CN103649759B (en) * 2011-03-22 2016-08-31 西维克公司 Microfluidic device and manufacture method and purposes
US9064301B2 (en) 2011-04-14 2015-06-23 Abbott Point Of Care, Inc. Method and apparatus for compressing imaging data of whole blood sample analyses
EP2748618A1 (en) * 2011-08-24 2014-07-02 Abbott Point of Care Inc. Biologic fluid sample analysis cartridge
CN103917870B (en) 2011-11-16 2016-04-13 贝克顿·迪金森公司 For detecting the method and system of the analysis thing in sample
CN107064079A (en) 2011-12-30 2017-08-18 艾博特健康公司 For recognizing the hematoblastic method and apparatus in whole blood sample
EP2797695A1 (en) 2011-12-30 2014-11-05 Abbott Point Of Care, Inc. Method for rapid imaging of biologic fluid samples
US9199236B2 (en) 2011-12-31 2015-12-01 Abbott Point Of Care, Inc. Biologic fluid sample analysis cartridge with sample collection port
WO2014089468A1 (en) 2012-12-06 2014-06-12 Abbott Point Of Care, Inc. Imaging biologic fluids using a predetermined distribution
BR112015010695A2 (en) 2013-01-11 2017-07-11 Becton Dickinson Co low cost point tester
CN105074404B (en) * 2013-02-19 2018-06-19 艾博特健康公司 Biologicfluid sample analysis box with non-reflective bead
US9518920B2 (en) 2013-06-26 2016-12-13 Alentic Microscience Inc. Sample processing improvements for microscopy
US20150030215A1 (en) * 2013-07-26 2015-01-29 Abbott Point Of Care, Inc. Method and apparatus for producing an image of undiluted whole blood sample having wright stain coloration
CN106029863A (en) 2013-11-06 2016-10-12 贝克顿·迪金森公司 Microfluidic devices, and methods of making and using the same
WO2015073384A1 (en) 2013-11-13 2015-05-21 Becton, Dickinson And Company Microimager analysis system comprising optics and methods of use thereof
US10482595B2 (en) 2014-08-27 2019-11-19 S.D. Sight Diagnostics Ltd. System and method for calculating focus variation for a digital microscope
AU2015334046B2 (en) 2014-10-14 2017-04-13 Becton, Dickinson And Company Blood sample management using open cell foam
US10625259B1 (en) 2014-11-26 2020-04-21 Medica Corporation Automated microscopic cell analysis
US20170326549A1 (en) 2014-11-26 2017-11-16 Ronald Jones Automated microscopic cell analysis
EP3381559A1 (en) 2015-03-10 2018-10-03 Becton, Dickinson and Company Biological fluid micro-sample management device
CN108700577A (en) * 2015-09-14 2018-10-23 Essenlix公司 For analyzing sample, especially blood, device and system and use its method and step
US10324009B2 (en) * 2015-08-10 2019-06-18 Essenlix Corporation Bio/chemical assay devices and methods for simplified steps, small samples, accelerated speed, and ease-of-use
EP3344390A1 (en) 2015-09-01 2018-07-11 Becton, Dickinson and Company Depth filtration device for separating specimen phases
US10132794B2 (en) * 2015-09-14 2018-11-20 Essenlix Corporation Device and system for collecting and analyzing vapor condensate, particularly exhaled breath condensate, as well as method of using the same
WO2017045712A1 (en) * 2015-09-16 2017-03-23 Siemens Healthcare Gmbh Arrangement and method for providing a sample for inspection by an imaging device
US10488644B2 (en) 2015-09-17 2019-11-26 S.D. Sight Diagnostics Ltd. Methods and apparatus for detecting an entity in a bodily sample
US10228367B2 (en) 2015-12-01 2019-03-12 ProteinSimple Segmented multi-use automated assay cartridge
KR20190020292A (en) * 2016-04-08 2019-02-28 알렌틱 마이크로사이언스 인코포레이티드 Sample processing for microscopic examination
CN107525805A (en) * 2016-06-20 2017-12-29 亿观生物科技股份有限公司 Sample testing apparatus and pattern detection system
EP3282262A1 (en) * 2016-08-10 2018-02-14 CytoScience SA Cassette for a microscope, microscope with such a cassette and method of microscoping with such a microscope
CN110312473A (en) 2016-12-21 2019-10-08 艾森利克斯公司 For authenticating the device and method and its use of sample
WO2018148342A1 (en) * 2017-02-07 2018-08-16 Essenlix Corporation Compressed open flow assay and use
WO2018152351A1 (en) * 2017-02-15 2018-08-23 Essenlix Corporation Assay with rapid temperature change
WO2018152422A1 (en) * 2017-02-16 2018-08-23 Essenlix Corporation Assay with textured surface
CA3052986A1 (en) * 2017-02-08 2018-08-16 Essenlix Corporation Molecular manipulation and assay with controlled temperature
WO2018148729A1 (en) * 2017-02-08 2018-08-16 Essenlix Corporation Qmax card-based assay devices and methods
CA3053005A1 (en) * 2017-02-08 2018-08-16 Essenlix Corporation Sample collection and handling for delayed analysis
CA3053125A1 (en) * 2017-02-09 2018-08-16 Essenlix Corporation Qmax assay and applications (ii)
JP2020510189A (en) * 2017-02-09 2020-04-02 エッセンリックス コーポレーション Assays that use different spacing heights
WO2019035084A1 (en) 2017-08-17 2019-02-21 Abbott Point Of Care Inc. A single-use test device for imaging blood cells
CN111164411A (en) 2017-08-17 2020-05-15 雅培医护站股份有限公司 Method of imaging assay beads in a biological sample
WO2019035085A1 (en) 2017-08-17 2019-02-21 Abbott Point Of Care Inc. A method of imaging blood cells
US20190056384A1 (en) 2017-08-17 2019-02-21 Abbott Point Of Care Inc. Single-use test device for imaging assay beads
WO2019148054A1 (en) * 2018-01-25 2019-08-01 Essenlix Corporation Assaying cells and non-cell analytes in a sample in parallel
WO2020037304A1 (en) * 2018-08-16 2020-02-20 Essenlix Corporation Assay using sample thickness multiplexing
WO2020106909A1 (en) * 2018-11-20 2020-05-28 Essenlix Corporation Apparatus and methods for rapid detection of acute phase reactants and white blood cells
USD893469S1 (en) 2018-11-21 2020-08-18 Essenlix Corporation Phone holder
USD893470S1 (en) 2018-11-28 2020-08-18 Essenlix Corporation Phone holder

Family Cites Families (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1049364A (en) * 1962-07-20 1966-11-23 Warner Lambert Pharmaceutical An apparatus for and a method of automatically analyzing a plurality of samples
US3447863A (en) * 1966-07-11 1969-06-03 Sodell Research & Dev Co Method for preparing a slide for viewing
US3607090A (en) * 1969-10-06 1971-09-21 Scientific Industries Analysis arrangment for multiple analyses of a single sample
US3879106A (en) 1973-04-11 1975-04-22 Pelam Inc Microscope slide cover slip
US4022521A (en) 1974-02-19 1977-05-10 Honeywell Inc. Microscope slide
US4171866A (en) 1978-04-20 1979-10-23 Tolles Walter E Disposable volumetric slide
US4218421A (en) * 1978-08-18 1980-08-19 Honeywell Inc. Disposable container for a continuous band of test strips
US4329054A (en) * 1979-08-16 1982-05-11 Spectron Development Laboratories, Inc. Apparatus for sizing particles, droplets or the like with laser scattering
US4264560A (en) * 1979-12-26 1981-04-28 Samuel Natelson Clinical analytical system
US4338024A (en) 1980-05-02 1982-07-06 International Remote Imaging Systems, Inc. Flow analyzer and system for analysis of fluids with particles
US4447140A (en) 1982-09-29 1984-05-08 Campbell Jeptha E Microscope slides
FR2565350B1 (en) * 1984-06-05 1986-10-10 Paris Nord Universite Proper means for allowing automatic continuous support, processing, storage and analysis of biological samples
US4689307A (en) 1986-09-02 1987-08-25 Caribbean Microparticles Corporation Fluorescence microscopy sample mounting method and structure
DE3721237A1 (en) * 1987-06-27 1989-01-05 Boehringer Mannheim Gmbh Diagnostic test carrier and method for the production thereof
US5039487A (en) 1987-12-22 1991-08-13 Board Of Regents, The University Of Texas System Methods for quantifying components in liquid samples
US4950455A (en) 1987-12-22 1990-08-21 Board Of Regents, University Of Texas System Apparatus for quantifying components in liquid samples
US5503803A (en) * 1988-03-28 1996-04-02 Conception Technologies, Inc. Miniaturized biological assembly
US5472671A (en) * 1989-04-26 1995-12-05 Nilsson; Sven-Erik Cuvette
US5184188A (en) * 1990-01-23 1993-02-02 Medical Devices Corporation Optical blood hemostatic analysis apparatus and method
US6176962B1 (en) 1990-02-28 2001-01-23 Aclara Biosciences, Inc. Methods for fabricating enclosed microchannel structures
SE470347B (en) 1990-05-10 1994-01-31 Pharmacia Lkb Biotech Microstructure fluid flow system and method for manufacturing such systems
US5321975A (en) 1991-10-04 1994-06-21 Levine Robert A Differential erythrocyte counts
EP0601205B1 (en) * 1992-06-26 1999-03-10 Daikin Industries, Ltd. Optical measurement instrument
FR2694918B1 (en) * 1992-08-21 1994-12-23 Millipore Sa Packaging forming an envelope for an object, method and device for opening such an envelope and removing an object from it, and microbiological analysis method using such packaging.
US5547849A (en) * 1993-02-17 1996-08-20 Biometric Imaging, Inc. Apparatus and method for volumetric capillary cytometry
US5585246A (en) 1993-02-17 1996-12-17 Biometric Imaging, Inc. Method for preparing a sample in a scan capillary for immunofluorescent interrogation
WO1995011621A1 (en) * 1993-10-28 1995-05-04 I-Stat Corporation Fluid sample collection and introduction device
CA2156226C (en) * 1994-08-25 1999-02-23 Takayuki Taguchi Biological fluid analyzing device and method
US5627041A (en) 1994-09-02 1997-05-06 Biometric Imaging, Inc. Disposable cartridge for an assay of a biological sample
US5504011A (en) * 1994-10-21 1996-04-02 International Technidyne Corporation Portable test apparatus and associated method of performing a blood coagulation test
NL1000607C1 (en) 1995-02-07 1996-08-07 Hendrik Jan Westendorp Counting chamber and method for manufacturing a counting chamber
NL9500281A (en) * 1995-02-15 1996-09-02 Jan Pieter Willem Vermeiden Counting chamber for biological research as well as a method for the production of such a counting chamber.
SE504193C2 (en) * 1995-04-21 1996-12-02 Hemocue Ab capillary microcuvette
US5641458A (en) * 1995-06-15 1997-06-24 Shockley, Jr.; H. David Flow through cell assembly
US6130098A (en) * 1995-09-15 2000-10-10 The Regents Of The University Of Michigan Moving microdroplets
US5726751A (en) * 1995-09-27 1998-03-10 University Of Washington Silicon microchannel optical flow cytometer
US5837547A (en) 1995-12-27 1998-11-17 Caribbean Microparticles Corporation Flow cytometer calibration method
US5985218A (en) * 1996-07-03 1999-11-16 Beckman Coulter, Inc. Reagent cartridge
AU4164597A (en) * 1996-08-26 1998-03-19 Princeton University Reversibly sealable microstructure sorting devices
US6573988B1 (en) * 1997-10-31 2003-06-03 Foss Electric A/S Cuvette and spacer therefor as well as a method of producing the spacer
US5968453A (en) * 1997-07-17 1999-10-19 Carolina Liquid Chemistries Corporation Reagent cartridge
US5812312A (en) * 1997-09-04 1998-09-22 Lorincz; Andrew Endre Microscope slide
US6016712A (en) 1997-09-18 2000-01-25 Accumetrics Device for receiving and processing a sample
EP1031834A4 (en) 1997-11-11 2004-11-24 Kowa Co Method of counting leukocytes and leukocyte counter
SE9800070D0 (en) 1998-01-14 1998-01-14 Hemocue Ab mixing method
US5948686A (en) 1998-03-07 1999-09-07 Robert A. Leuine Method for performing blood cell counts
US6235536B1 (en) 1998-03-07 2001-05-22 Robert A. Levine Analysis of quiescent anticoagulated whole blood samples
US6350613B1 (en) 1998-03-07 2002-02-26 Belton Dickinson & Co. Determination of white blood cell differential and reticulocyte counts
US6004821A (en) 1998-03-07 1999-12-21 Levine; Robert A. Method and apparatus for performing chemical, qualitative, quantitative, and semi-quantitative analyses of a urine sample
US6723290B1 (en) 1998-03-07 2004-04-20 Levine Robert A Container for holding biologic fluid for analysis
US6929953B1 (en) 1998-03-07 2005-08-16 Robert A. Levine Apparatus for analyzing biologic fluids
AU3413499A (en) * 1998-03-27 1999-10-18 Aventis Pharma Deutschland Gmbh Miniaturized microtiter plate for high throughput screening
CA2330556A1 (en) * 1998-05-13 1999-11-18 Bayer Corporation Optical spectroscopy sample cell
AU3771599A (en) 1998-05-18 1999-12-06 University Of Washington Liquid analysis cartridge
US6180314B1 (en) 1998-05-27 2001-01-30 Becton, Dickinson And Company Method for preparing thin liquid samples for microscopic analysis
US6261519B1 (en) * 1998-07-20 2001-07-17 Lifescan, Inc. Medical diagnostic device with enough-sample indicator
US6521182B1 (en) * 1998-07-20 2003-02-18 Lifescan, Inc. Fluidic device for medical diagnostics
DE19847617C2 (en) * 1998-10-15 2002-11-07 Sensor Instr Gmbh Method and device for measuring the length of the light guide
US6197593B1 (en) 1998-10-20 2001-03-06 Coulter International Corp. Method for enumerating blood cells
WO2000052446A1 (en) * 1999-03-02 2000-09-08 Qualigen, Inc. Methods and apparatus for separation of biological fluids
US6150178A (en) * 1999-03-24 2000-11-21 Avitar, Inc. Diagnostic testing device
EP1208189B1 (en) * 1999-05-28 2004-10-06 Cepheid Device and method for analysing liquid samples
US6448090B1 (en) 1999-07-09 2002-09-10 Orchid Biosciences, Inc. Fluid delivery system for a microfluidic device using alternating pressure waveforms
US6395232B1 (en) 1999-07-09 2002-05-28 Orchid Biosciences, Inc. Fluid delivery system for a microfluidic device using a pressure pulse
US6365111B1 (en) * 1999-08-25 2002-04-02 Randall C. Bass Holder for specimen examination
DE19941905C2 (en) * 1999-09-02 2002-06-06 Max Planck Gesellschaft Sample chamber for the liquid treatment of biological samples
CA2389228A1 (en) 1999-10-29 2001-05-10 Barry Wenz Biological fluid processing
US6420114B1 (en) * 1999-12-06 2002-07-16 Incyte Genomics, Inc. Microarray hybridization chamber
US8828320B2 (en) 2004-05-14 2014-09-09 Honeywell International Inc. Portable sample analyzer cartridge
US20060263888A1 (en) 2000-06-02 2006-11-23 Honeywell International Inc. Differential white blood count on a disposable card
DE10033268C2 (en) * 2000-07-10 2002-08-08 Innovatis Gmbh Method for examining cells in a culture fluid
US6597438B1 (en) 2000-08-02 2003-07-22 Honeywell International Inc. Portable flow cytometry
US7277166B2 (en) 2000-08-02 2007-10-02 Honeywell International Inc. Cytometer analysis cartridge optical configuration
US7978329B2 (en) 2000-08-02 2011-07-12 Honeywell International Inc. Portable scattering and fluorescence cytometer
JP2002214241A (en) 2000-11-20 2002-07-31 Minolta Co Ltd Microchip
US6613286B2 (en) * 2000-12-21 2003-09-02 Walter J. Braun, Sr. Apparatus for testing liquid/reagent mixtures
US6809828B2 (en) 2001-01-25 2004-10-26 Texas Tech University Universal detector for biological and chemical separations or assays using plastic microfluidic devices
US7010391B2 (en) * 2001-03-28 2006-03-07 Handylab, Inc. Methods and systems for control of microfluidic devices
US6902534B2 (en) 2001-03-30 2005-06-07 Becton, Dickinson And Company Method and kit of components for delivering blood to a portable clinical analyzer
AT414469T (en) 2001-06-08 2008-12-15 Hoffmann La Roche Removal device for body flows
US7179423B2 (en) * 2001-06-20 2007-02-20 Cytonome, Inc. Microfluidic system including a virtual wall fluid interface port for interfacing fluids with the microfluidic system
KR100425536B1 (en) * 2001-07-16 2004-03-30 학교법인 포항공과대학교 Bread board for microfluidic chip
US7943093B2 (en) * 2001-12-12 2011-05-17 Erie Scientific Company Cover slip
SE0201738D0 (en) * 2002-06-07 2002-06-07 Aamic Ab Micro-fluid Structures
US7351379B2 (en) * 2002-06-14 2008-04-01 Agilent Technologies, Inc. Fluid containment structure
US7000330B2 (en) 2002-08-21 2006-02-21 Honeywell International Inc. Method and apparatus for receiving a removable media member
US7220593B2 (en) * 2002-10-03 2007-05-22 Battelle Memorial Institute Buffy coat separator float system and method
TW587694U (en) 2003-03-14 2004-05-11 Mau-Guei Jang Protruded platform type quantitative cell counter plate
JP5118849B2 (en) 2003-03-17 2013-01-16 チャールズ リバー ラボラトリーズ, インコーポレイテッド Methods and compositions for detection of microbial contaminants
US7364699B2 (en) 2003-06-18 2008-04-29 Bayer Healthcare Llc Containers for reading and handling diagnostic reagents and methods of using the same
US7723099B2 (en) * 2003-09-10 2010-05-25 Abbott Point Of Care Inc. Immunoassay device with immuno-reference electrode
US7671974B2 (en) * 2003-10-29 2010-03-02 Chf Solutions Inc. Cuvette apparatus and system for measuring optical properties of a liquid such as blood
US7468160B2 (en) * 2003-12-05 2008-12-23 Agilent Technologies, Inc. Devices and methods for performing array based assays
KR100572207B1 (en) * 2003-12-18 2006-04-19 주식회사 디지탈바이오테크놀러지 Bonding method of plastic microchip
EP1733226B1 (en) 2004-04-07 2015-07-29 Levine, Robert Aaron Disposable chamber for analyzing biologic fluids
US8916348B2 (en) * 2004-05-06 2014-12-23 Clondiag Gmbh Method and device for the detection of molecular interactions
WO2005111580A1 (en) 2004-05-07 2005-11-24 Optiscan Biomedical Corporation Sample element with fringing-reduction capabilities
US7641856B2 (en) 2004-05-14 2010-01-05 Honeywell International Inc. Portable sample analyzer with removable cartridge
US8071051B2 (en) 2004-05-14 2011-12-06 Honeywell International Inc. Portable sample analyzer cartridge
US8097225B2 (en) * 2004-07-28 2012-01-17 Honeywell International Inc. Microfluidic cartridge with reservoirs for increased shelf life of installed reagents
US7381374B2 (en) * 2004-09-22 2008-06-03 Hsiao-Chung Tsai Immunoassay devices and methods of using same
SE528697C2 (en) 2005-03-11 2007-01-30 Hemocue Ab Volumetric determination of the number of white blood cells in a blood sample
SE528638C2 (en) 2005-04-08 2007-01-09 Boule Medical Ab Device for filling a device for determining a sample volume
US7803319B2 (en) 2005-04-29 2010-09-28 Kimberly-Clark Worldwide, Inc. Metering technique for lateral flow assay devices
JP2007033350A (en) * 2005-07-29 2007-02-08 Hitachi High-Technologies Corp Chemical analyzing apparatus
US7731901B2 (en) * 2005-10-19 2010-06-08 Abbott Laboratories Apparatus and method for performing counts within a biologic fluid sample
US8936945B2 (en) 2005-11-17 2015-01-20 The Regents Of The University Of Michigan Compositions and methods for liquid metering in microchannels
US7976795B2 (en) 2006-01-19 2011-07-12 Rheonix, Inc. Microfluidic systems
SE531233C2 (en) 2006-03-28 2009-01-27 Hemocue Ab Device and method for detection of biological components fluorecensmärkta
US20080176253A1 (en) 2006-05-10 2008-07-24 The Board Of Regents Of The University Of Texas System Detecting human or animal immunoglobin-e
EP1878497A1 (en) 2006-07-14 2008-01-16 Boehringer Mannheim Gmbh Disposable for analyzing a liquid sample by nucleic acid amplification
FR2908999B1 (en) * 2006-11-29 2012-04-27 Biomerieux Sa Novel drug for the inhibition, prevention or treatment of rheumatoid arthritis.
US7802467B2 (en) 2006-12-22 2010-09-28 Abbott Diabetes Care Inc. Analyte sensors and methods of use
GB2445738A (en) 2007-01-16 2008-07-23 Lab901 Ltd Microfluidic device
JP4894526B2 (en) * 2007-01-17 2012-03-14 横河電機株式会社 Chemical reaction cartridge
US7738094B2 (en) 2007-01-26 2010-06-15 Becton, Dickinson And Company Method, system, and compositions for cell counting and analysis
WO2008101196A1 (en) * 2007-02-15 2008-08-21 Osmetech Molecular Diagnostics Fluidics devices
RU2010101672A (en) 2007-06-20 2011-07-27 Мек Дайнэмикс Корпорэйшн (Us) Methods and device for measuring blood collability
TW200920841A (en) 2007-09-25 2009-05-16 Cytyc Corp Microfluidic apparatus for manipulating imaging and analyzing cells of a cytological specimen
EP2050498A1 (en) 2007-10-19 2009-04-22 Philips Electronics N.V. Fluid handling device for analysis of fluid samples
DK2209554T3 (en) * 2007-11-13 2018-01-15 F Hoffmann-La Roche Ag Modular sensor cassette
EP2081018A1 (en) * 2008-01-18 2009-07-22 F.Hoffmann-La Roche Ag Gas sensor with microporous electrolyte layer
US20120004139A1 (en) * 2008-02-01 2012-01-05 Complete Genomics, Inc. Flow cells for biochemical analysis
JP5539309B2 (en) 2008-03-21 2014-07-02 アボット ポイント オブ ケア インコーポレイテッド Method and apparatus for determining the red blood cell index of a blood sample using the inherent dye of hemoglobin contained in red blood cells
WO2009117682A1 (en) 2008-03-21 2009-09-24 Abbott Point Of Care, Inc. Method and apparatus for detecting and counting platelets individually and in aggregate clumps
ES2392380T3 (en) * 2008-03-21 2012-12-10 Abbott Point Of Care, Inc. Procedure and apparatus for determining the hematocrit of a blood sample using the intrinsic pigmentation of the hemoglobin contained in the red blood cells
CN102084241B (en) 2008-03-21 2015-02-18 艾博特健康公司 Method and apparatus for analyzing individual cells or particulates using fluorescent quenching and/or bleaching
CN102047114B (en) 2008-04-02 2014-10-29 艾博特健康公司 Self-calibrating gradient dilution in a constituent assay and gradient dilution apparatus performed in a thin film sample
JP5734838B2 (en) 2008-04-09 2015-06-17 アボット ポイント オブ ケア インコーポレイテッド Method for measuring the area of a sample placed in an analysis chamber
US20100189338A1 (en) 2008-04-09 2010-07-29 Nexcelom Bioscience Systems and methods for counting cells and biomolecules
CN102047116A (en) 2008-04-09 2011-05-04 艾博特健康公司 Method of detecting very low levels of analyte within a thin film fluid sample contained in a thin thickness chamber
KR100960066B1 (en) 2008-05-14 2010-05-31 삼성전자주식회사 Microfluidic device containing lyophilized reagent therein and analysing method using the same
US7976789B2 (en) 2008-07-22 2011-07-12 The Board Of Trustees Of The University Of Illinois Microfluidic device for preparing mixtures
DE102009015395A1 (en) 2009-03-23 2010-09-30 Thinxxs Microtechnology Ag Micro fluid cell, for analysis and diagnosis of e.g. blood, has a pressure zone to transport the fluid through channels to chambers containing reagents and through a detection chamber
CA2784353C (en) 2009-12-18 2015-11-03 Abbott Point Of Care, Inc. Biologic fluid analysis cartridge
EP2519820B1 (en) 2009-12-31 2013-11-06 Abbott Point Of Care, Inc. Method and apparatus for determining mean cell volume of red blood cells
WO2011116305A1 (en) 2010-03-18 2011-09-22 Abbott Point Of Care, Inc. Method and apparatus for optically determining at least one hemoglobin related parameter of a whole blood sample
BR112013000017A2 (en) 2010-07-05 2016-05-24 Koninkl Philips Electronics Nv method for examining a sample in a cartridge with an inlet and a reaction chamber, a cartridge for examining a sample and a apparatus for examining a sample
AU2011285527B2 (en) 2010-08-05 2014-10-30 Abbott Point Of Care, Inc. Method and apparatus for automated whole blood sample analyses from microscopy images

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
WO2005100539A3 (en) 2006-01-19
AU2005233571B2 (en) 2008-10-09
US20110294198A1 (en) 2011-12-01
EP2977757A1 (en) 2016-01-27
US9084995B2 (en) 2015-07-21
EP1733226A4 (en) 2011-07-13
EP1733226B1 (en) 2015-07-29
US8241572B2 (en) 2012-08-14
ES2643836T3 (en) 2017-11-24
CA2563002A1 (en) 2005-10-27
CN1957254B (en) 2012-01-25
US20150323519A1 (en) 2015-11-12
US20100216248A1 (en) 2010-08-26
US7850916B2 (en) 2010-12-14
CN1957254A (en) 2007-05-02
EP3270156A1 (en) 2018-01-17
JP4362532B2 (en) 2009-11-11
US10578602B2 (en) 2020-03-03
US20070243117A1 (en) 2007-10-18
ES2548567T3 (en) 2015-10-19
CA2563002C (en) 2011-07-12
EP1733226A2 (en) 2006-12-20
WO2005100539A2 (en) 2005-10-27
AU2005233571A1 (en) 2005-10-27
JP2007532881A (en) 2007-11-15

Similar Documents

Publication Publication Date Title
US10159978B2 (en) Flow control in microfluidic systems
JP5711800B2 (en) Method and apparatus for determining the red blood cell index of a blood sample using the inherent dye of hemoglobin contained in red blood cells
US20190366338A1 (en) Kits and devices for detecting analytes
US20170115289A1 (en) Image analysis and measurement of biological samples
US9993817B2 (en) Biologic fluid analysis cartridge
US10345217B2 (en) Flowcell systems and methods for particle analysis in blood samples
JP6031178B2 (en) Disposable chip type flow cell and cell sorter using the same
RU2620922C2 (en) Systems and methods for optimization of sample use
US10508983B2 (en) Method for performing a blood count and determining the morphology of a blood smear
US9757729B2 (en) Microfluidic device
JP2019045509A (en) Image analysis and measurement of biological samples
US10744501B2 (en) Microchip and particulate analyzing device
US7553453B2 (en) Assay implementation in a microfluidic format
CN102084241B (en) Method and apparatus for analyzing individual cells or particulates using fluorescent quenching and/or bleaching
US6350613B1 (en) Determination of white blood cell differential and reticulocyte counts
TW408037B (en) Analytical test element with a capillary channel
US10093957B2 (en) Method, kit and system for imaging a blood sample
CA2109704C (en) Analytical cartridge and system for detecting analytes
US9442106B2 (en) Simple and affordable method for immunophenotyping using a microfluidic chip sample preparation with image cytometry
US5302515A (en) Chemotactic test apparatus and method
DE69910006T2 (en) Flow cuvet for spectroscopic examination of a sample
US7641856B2 (en) Portable sample analyzer with removable cartridge
EP0679195B1 (en) Multiple-site chemotactic test apparatus and method
EP1581798B1 (en) Male fertility assay method and device
EP1377811B1 (en) Split focusing cytometer

Legal Events

Date Code Title Description
AC Divisional application: reference to earlier application

Ref document number: 1733226

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

RAP1 Rights of an application transferred

Owner name: ABBOTT LABORATORIES

RBV Designated contracting states (corrected)

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

17P Request for examination filed

Effective date: 20160727

INTG Intention to grant announced

Effective date: 20170321

AC Divisional application: reference to earlier application

Ref document number: 1733226

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 928658

Country of ref document: AT

Kind code of ref document: T

Effective date: 20171015

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602005052741

Country of ref document: DE

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2643836

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20171124

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20170913

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 928658

Country of ref document: AT

Kind code of ref document: T

Effective date: 20170913

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171213

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171214

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 14

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180113

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602005052741

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

26N No opposition filed

Effective date: 20180614

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20180430

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180407

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180430

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180430

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180407

PGFP Annual fee paid to national office [announced from national office to epo]

Ref country code: IT

Payment date: 20190415

Year of fee payment: 15

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

PGFP Annual fee paid to national office [announced from national office to epo]

Ref country code: GB

Payment date: 20200327

Year of fee payment: 16

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20050407

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

PGFP Annual fee paid to national office [announced from national office to epo]

Ref country code: FR

Payment date: 20200320

Year of fee payment: 16

PGFP Annual fee paid to national office [announced from national office to epo]

Ref country code: DE

Payment date: 20200317

Year of fee payment: 16

Ref country code: ES

Payment date: 20200505

Year of fee payment: 16